ArticleVeterinary and comparative oncology2020

The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.

Fernando Alegre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.